{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T19:37:25Z","timestamp":1787600245651,"version":"build-2736575974"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Dermatol Surg","DS"],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND<\/jats:title>\n                    <jats:p>Botulinum toxin type A (BoNT-A) is widely used in dermatology, yet data on its safety during pregnancy and lactation remain limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>To survey US dermatologists on reported practices and personal experiences with BoNT-A use during pregnancy and lactation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>MATERIALS AND METHODS<\/jats:title>\n                    <jats:p>A cross-sectional survey was distributed to US board-certified dermatologists through a professional networking group on a social media platform. Respondents reported whether they had administered or personally received BoNT-A during pregnancy or lactation. Participation was voluntary, and responses were deidentified prior to analysis. The survey remained open for 2 weeks and intended for exploratory analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>\n                      Of 177 respondents, 75% (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 133) reported administering or receiving botulinum toxin while breast-feeding, with no reported adverse effects. Use during pregnancy was reported by 8% in the first trimester, 5% in the second, and 7% in the third. No fetal complications were reported.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION<\/jats:title>\n                    <jats:p>Botulinum toxin type A use during lactation was reported among many dermatologists in this survey with no reported adverse outcomes. Use during pregnancy was less frequent and approached more conservatively. These exploratory findings should be hypothesis-generating rather than evidence of safety, highlighting the gap between current self-practice and available safety data, underscoring the need for controlled studies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/dss.0000000000004997","type":"journal-article","created":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T21:00:17Z","timestamp":1767819617000},"page":"653-656","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Practice Versus Protocol: A Survey of Current Botulinum Toxin Use During Lactation and Pregnancy in Dermatology"],"prefix":"10.1097","volume":"52","author":[{"given":"Jennifer","family":"Cucalon","sequence":"first","affiliation":[{"name":"HCA Florida Healthcare\/USF Morsani College of Medicine , Department of GME, Hudson, Florida;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Drew","family":"Taylor","sequence":"additional","affiliation":[{"name":"Epiphany Dermatology, Aspen, Colorado;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanislav N.","family":"Tolkachjov","sequence":"additional","affiliation":[{"name":"Epiphany Dermatology, Dallas, Texas;"},{"name":"Department of Dermatology, University of Texas at Southwestern, Dallas, Texas;"},{"name":"Texas A&M School of Medicine, Dallas, Texas;"},{"name":"Division of Dermatology, Baylor University Medical Center, Dallas, Texas;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moises","family":"Lutwak","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Larkin Community Hospital, South Miami, Florida;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Weiss","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Cutaneous Surgery, University of Miami, Miami, Florida;"},{"name":"Hollywood Dermatology and Cosmetic Specialists, Hollywood, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,12,31]]},"reference":[{"key":"R2-20260624","first-page":"e67961","article-title":"A systematic review and comparative analysis of Botox treatment in aesthetic and therapeutic applications: advantages, disadvantages, and patient outcomes","volume":"16","author":"Meretsky","year":"2024","journal-title":"Cureus"},{"key":"R3-20260624","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1111\/dsu.12322","article-title":"Safety of cosmetic dermatologic procedures during pregnancy","volume":"39","author":"Lee","year":"2013","journal-title":"Dermatol Surg"},{"key":"R5-20260624","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40268-014-0077-1","article-title":"Pharmaceutical, biological, and clinical properties of botulinum neurotoxin type A products","volume":"15","author":"Frevert","year":"2015","journal-title":"Drugs R D"},{"key":"R6-20260624","first-page":"1183","article-title":"Botulinum toxin type A in pregnancy","volume":"59","author":"Tan","year":"2013","journal-title":"Can Fam Physician"},{"key":"R7-20260624","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ijwd.2017.01.005","article-title":"A review of the safety of cosmetic procedures during pregnancy and lactation","volume":"3","author":"Trivedi","year":"2017","journal-title":"Int J Womens Dermatol"},{"key":"R8-20260624","first-page":"328970","article-title":"Achalasia in pregnancy: botulinum toxin A injection of lower esophageal sphincter","volume":"2015","author":"Hooft","year":"2015","journal-title":"Case Rep Surg"},{"key":"R9-20260624","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/j.1540-9740.2006.05584.x","article-title":"Botulinum toxin and pregnancy","volume":"5","author":"de Oliveira Monteiro","year":"2006","journal-title":"Skinmed."},{"key":"R10-20260624","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/mdc3.12135","article-title":"Safe administration of botulinum toxin type A injections during pregnancy: a report of two cases","volume":"2","author":"Krug","year":"2015","journal-title":"Mov Disord Clin Pract"},{"key":"R12-20260624","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.1212\/WNL.0000000000207375","article-title":"Pregnancy outcomes in patients exposed to onabotulinumtoxinA treatment: a cumulative 29-year safety update","volume":"101","author":"Brin","year":"2023","journal-title":"Neurology"},{"key":"R13-20260624","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1097\/GRF.0000000000000142","article-title":"Drugs in breast milk","volume":"58","author":"Newton","year":"2015","journal-title":"Clin Obstet Gynecol"},{"key":"R14-20260624","doi-asserted-by":"crossref","first-page":"e796","DOI":"10.1542\/peds.2013-1985","article-title":"The transfer of drugs and therapeutics into human breast milk: an update on selected topics","volume":"132","author":"Sachs","year":"2013","journal-title":"Pediatrics"},{"key":"R15-20260624","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1097\/01.grf.0000135653.56778.3f","article-title":"Maternal medications during breastfeeding","volume":"47","author":"Hale","year":"2004","journal-title":"Clin Obstet Gynecol"},{"key":"R16-20260624","first-page":"423","article-title":"Use of drugs during breastfeeding","volume":"16","author":"Berlin","year":"1995","journal-title":"Pediatr Rev"},{"key":"R17-20260624","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1080\/23744235.2021.1919753","article-title":"Infant botulism: an underestimated threat","volume":"53","author":"Antonucci","year":"2021","journal-title":"Infect Dis (Lond)"},{"key":"R18-20260624","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/s00284-024-03828-0","article-title":"Infant botulism: in search of Clostridium botulinum spores","volume":"81","author":"Harris","year":"2024","journal-title":"Curr Microbiol"},{"key":"R20-20260624","first-page":"165","article-title":"Adalimumab drug levels in breast milk of nursing mothers with inflammatory bowel disease","volume":"9","author":"Ben-Horin","year":"2015","journal-title":"J Crohns Colitis"},{"key":"R21-20260624","first-page":"1054","article-title":"Certolizumab pegol use during breastfeeding: transfer into breast milk and minimal exposure in infant serum","volume":"68","author":"F\u00f6rger","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"R22-20260624","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.cgh.2012.11.011","article-title":"Placental transfer of anti-TNF agents in pregnant patients with inflammatory bowel disease","volume":"11","author":"Mahadevan","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R23-20260624","first-page":"408","article-title":"Pregnancy outcomes in patients with moderate-to-severe psoriasis treated with secukinumab","volume":"156","author":"Clowse","year":"2020","journal-title":"JAMA Dermatol"},{"key":"R24-20260624","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1136\/jnnp.2005.063792","article-title":"Botulinum toxin A during pregnancy: a survey of treating physicians","volume":"77","author":"Morgan","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R25-20260624","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1089\/fpsam.2023.0326","article-title":"Analysis of breast milk samples in lactating women after undergoing botulinum toxin injections for facial rejuvenation: a pilot study","volume":"26","author":"Hudson","year":"2024","journal-title":"Facial Plast Surg Aesthet Med"},{"key":"R26-20260624","doi-asserted-by":"crossref","first-page":"108","DOI":"10.4103\/JCAS.JCAS_226_20","article-title":"Dermatologic and cosmetic procedures in pregnancy","volume":"15","author":"Garg","year":"2022","journal-title":"J Cutan Aesthet Surg"}],"container-title":["Dermatologic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DSS.0000000000004997","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T04:00:47Z","timestamp":1782273647000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/DSS.0000000000004997"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,31]]},"references-count":22,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/dss.0000000000004997","relation":{},"ISSN":["1076-0512","1524-4725"],"issn-type":[{"value":"1076-0512","type":"print"},{"value":"1524-4725","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,31]]}}}